A long-used gout medication, colchicine, may significantly lower the risk of heart attacks and strokes in people with cardiovascular disease. A major Cochrane review of nearly 23,000 patients found meaningful reductions in repeat heart events using low-dose colchicine, with mostly mild side effects. Researchers say it offers an affordable preventive option.